Department of Physical Medicine and Rehabilitation, University of Michigan, North Campus Research Complex, 2800 Plymouth Road, Building NCRC B14, Room G216, Ann Arbor, MI, 48109-2800, USA.
Department of Medical Social Sciences, Northwestern University, Chicago, IL, USA.
J Neurol. 2018 Jan;265(1):98-107. doi: 10.1007/s00415-017-8677-7. Epub 2017 Nov 15.
Huntington disease is a fatal inherited neurodegenerative disease. Because the end result of Huntington disease is death due to Huntington disease-related causes, there is a need for better understanding and caring for individuals at their end of life.
The purpose of this study was to develop a new measure to evaluate end of life planning.
We conducted qualitative focus groups, solicited expert input, and completed a literature review to develop a 16-item measure to evaluate important aspects of end of life planning for Huntington disease. Item response theory and differential item functioning analyses were utilized to examine the psychometric properties of items; exploratory factor analysis was used to establish meaningful subscales.
Participants included 508 individuals with pre-manifest or manifest Huntington disease.
Item response theory supported the retention of all 16 items on the huntington disease quality of life ("HDQLIFE") end of life planning measure. Exploratory factor analysis supported a four-factor structure: legal planning, financial planning, preferences for hospice care, and preferences for conditions (locations, surroundings, etc.) at the time of death. Although a handful of items exhibited some evidence of differential item functioning, these items were retained due to their relevant clinical content. The final 16-item scale includes an overall total score and four subscale scores that reflect the different end of life planning constructs.
The 16-item HDQLIFE end of life planning measure demonstrates adequate psychometric properties; it may be a useful tool for clinicians to clarify patients' preferences about end of life care.
亨廷顿病是一种致命的遗传性神经退行性疾病。由于亨廷顿病的最终结果是由于亨廷顿病相关原因导致的死亡,因此需要更好地了解和关心生命末期的个体。
本研究旨在开发一种新的评估生命末期规划的工具。
我们进行了定性焦点小组讨论,征求了专家意见,并进行了文献回顾,以开发一种评估亨廷顿病生命末期规划的 16 项措施。项目反应理论和差异项目功能分析用于评估项目的心理测量特性;探索性因素分析用于建立有意义的子量表。
参与者包括 508 名有前驱期或显性亨廷顿病的个体。
项目反应理论支持保留亨廷顿病生活质量量表(“HDQLIFE”)生命末期规划措施的所有 16 项。探索性因素分析支持了四个因素结构:法律规划、财务规划、临终关怀偏好以及死亡时的条件(地点、环境等)偏好。尽管少数项目表现出一些差异项目功能的证据,但由于这些项目具有相关的临床内容,因此保留了这些项目。最终的 16 项量表包括一个总体总分和四个子量表分数,反映了不同的生命末期规划结构。
16 项 HDQLIFE 生命末期规划措施具有足够的心理测量特性;它可能是临床医生澄清患者对生命末期护理偏好的有用工具。